series-c-plus
Stage
1
Investors
About
Bruker Cellular Analysis develops hardware platforms for live single-cell functional analysis using optofluidic and proteomic barcoding technologies to accelerate antibody discovery, cell therapy development, and cell line development.
Explore Bruker Cellular Analysis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.